The application of GLP-1 receptor agonists in obesity due to MC4R deficiency Metab Target Organ Damage
Interestingly, it also stimulates insulin secretion from -cells, but with much lower potency than GLP-1 with the mechanism potentially due to the weak binding of glucagon at GLP-1 receptor site [11]
GLP-1 medications, including Ozempic and Wegovy, are prescription treatments that should only be used under the supervision of a licensed healthcare provider
10.1016/j.tem.2016.03.017 17 ChenL.YunY.GuoS.WangX.XiongM.ZhaoT.et al (2023)
Abstract Background: GLP-1 receptor agonists (GLP-1RAs) address key metabolic drivers of Polycystic Ovary Syndrome (PCOS), yet their integration into fertility management remains challenging because reproductive efficacy is variably reported, preconception washout is required, and standardized clinical pathways are lacking
GLP1 receptor agonists such as liraglutide, semaglutide, and dulaglutide are widely used in the management of type 2 diabetes and increasingly for weight management in people with and without diabetes
